ATRION Corporation is a medical instruments & supplies business based in the US. ATRION Corporation shares (ATRI) are listed on the NASDAQ and all prices are listed in US Dollars. ATRION Corporation employs 712 staff and has a trailing 12-month revenue of around $181.6 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.00 |
|---|---|
| 52-week range | $270.22 - $500.80 |
| 50-day moving average | $457.07 |
| 200-day moving average | $410.03 |
| Wall St. target price | $300.00 |
| PE ratio | 64.5049 |
| Dividend yield | $8.8 (1.91%) |
| Earnings per share (TTM) | $7.13 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0 from 2024-08-23
| 1 week (2024-08-24) | nan% |
|---|---|
| 1 month (2024-08-02) | -100.00% |
| 3 months (2024-06-04) | -100.00% |
| 6 months (2024-03-04) | -100.00% |
| 1 year (2023-09-01) | -100.00% |
|---|---|
| 2 years (2022-09-02) | -100.00% |
| 3 years (2021-09-03) | 714.99 |
| 5 years (2019-09-04) | 741.456 |
Valuing ATRION Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of ATRION Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
ATRION Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 65x. In other words, ATRION Corporation shares trade at around 65x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
ATRION Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $32.5 million.
The EBITDA is a measure of a ATRION Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $181.6 million |
|---|---|
| Operating margin TTM | 1.1% |
| Gross profit TTM | $75.9 million |
| Return on assets TTM | 3.96% |
| Return on equity TTM | 5.23% |
| Profit margin | 6.92% |
| Book value | $135.72 |
| Market Capitalization | $809.4 million |
TTM: trailing 12 months
Dividend payout ratio: 123.4% of net profits
Recently ATRION Corporation has paid out, on average, around 123.4% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.91% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), ATRION Corporation shareholders could enjoy a 1.91% return on their shares, in the form of dividend payments. In ATRION Corporation's case, that would currently equate to about $8.8 per share.
ATRION Corporation's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
ATRION Corporation's most recent dividend payout was on 27 June 2024. The latest dividend was paid out to all shareholders who bought their shares by 13 June 2024 (the "ex-dividend date").
ATRION Corporation's shares were split on a 3:2 basis on 2 December 1996. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your ATRION Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for ATRION Corporation shares which in turn could have impacted ATRION Corporation's share price.
Over the last 12 months, ATRION Corporation's shares have ranged in value from as little as $270.2231 up to $500.8014. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ATRION Corporation's is 0.688. This would suggest that ATRION Corporation's shares are less volatile than average (for this exchange).
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
Advanced Micro Devices (AMD), Intel Corporation (INTC) and Qualcomm Inc (QCOM) are top stocks like Nvidia. See our full list here.
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
A deep dive into the highlights and limitations of Frec.
Compare pros, cons, research tools and reviews for these two trading platforms.
What you need to know about investing in the leading indicator for the overall US stock market.
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.